Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 8,350

Document Document Title
WO/2024/084122A1
The present invention relates to the use of BODIPY-derived compounds to detect drugs such as scopolamine, ketamine and cathinones. When the chromophore BODIPY is combined with copper salts, its colour and fluorescence change in the prese...  
WO/2024/081453A1
Novel high purity dimethylaluminium chloride compositions are provided that are suitable for semiconductor applications, such as atomic layer etch and aluminum ion implantation. The reduction or minimization of specified gaseous impuriti...  
WO/2024/077407A1
Disclosed in the present invention are a chiral reducing agent and a method for synthesizing chiral nicotine. The chiral reducing agent is a compound 1 or a compound 2, or a stereoisomer of the compound 1 and the compound 2. The structur...  
WO/2024/074352A1
Provided is a chelate complex comprising (a) a rare earth metal cation M; (b) a chelate ligand of formula (CL1 A) or (CL1 B) c) at least one anionic nucleophilic ligand LN which is coordinated as a further ligand to the rare earth metal ...  
WO/2024/074648A1
The present invention relates to a method for precipitating the gadolinium complex of formula (I) from a solution comprising such gadolinium complex by means of mixing a first solution comprising the complex with a second solution, as we...  
WO/2024/075537A1
The present invention addresses the problem of providing a reactive compound having excellent storage stability. The present invention relates to a reactive compound represented by formula (1). (In formula (1), Ar1 denotes an aromatic ...  
WO/2024/066619A1
The present application provides an organic compound having a general formula of , wherein at least one of ring A, ring A-Y, ring B, ring B-Y, and R has a structure of . The present application also provides a preparation method and use ...  
WO/2024/067923A1
The invention relates to a chemical composition, an optoelectronic component (10) comprising at least one chemical composition of this type, and a use of at least one chemical composition of this type in an optolectronic component (10).  
WO/2024/064210A1
Disclosed are compounds, compositions, and methods useful for boron neutron capture therapy.  
WO/2024/063095A1
The prevent invention provides a radiolabeled tyrosine derivative which has excellent LAT1 selectability, higher retention at a tumor or cancer site, and a degree of clearance that does not cause side effects, and which can be safely man...  
WO/2024/062200A1
The invention relates to a method for producing a MOF, wherein a MOF is a structured metal-organic compound comprising a two- or three-dimensional porous network consisting of inorganic entities that are connected by polydentate chelatin...  
WO/2024/063529A1
The present invention relates to a novel compound and an MRI contrast medium comprising same, the compound having, as a functional group, flavonoids, which are one of natural products having anti-inflammatory, antioxidant and anti-cancer...  
WO/2024/055196A1
The present invention relates to an acceptor-donor-acceptor (A-D-A) type organic compound and a preparation method therefor. The material has a thermal activation delayed fluorescence property; a monomolecular structure presents a face-t...  
WO/2024/055195A1
The present invention relates to a high-efficiency organic electroluminescent device and a preparation method therefor. A hole injection layer, a hole transport layer, an electron blocking layer, a light-emitting layer, a hole blocking l...  
WO/2024/058103A1
The purpose of the present invention is to provide a compound and a colored resin composition which make it possible to produce an optical filter having improved solvent resistance (and preferably, improved solvent resistance, heat resis...  
WO/2024/059650A2
Theranostic agents for targeting Gastrin Releasing Peptide Receptor (GRPR) and Prostate Specific Membrane Antigen (PSMA) expressing cells, and use of these agents for detection, staging, and therapy of primary and metastatic prostate can...  
WO/2024/054972A2
The present invention provides a compound having the structure: or salt or ester thereof.  
WO/2024/052549A1
The present invention relates to a new class of compounds of general formula (I), to the metal chelates with a metal ion suitable for computed tomography thereof, to the Gd3+ chelate complexes thereof, to methods of preparing said compou...  
WO/2024/052250A1
The present invention relates to the use of an aminoborane for the preparation of an alkenylaminoborane from a catalyst-free alkyne or in the presence of a catalyst selected from the group of acids consisting of carboxylic acids, sulfoni...  
WO/2024/049087A1
Disclosed in the present invention are a novel compound based on pyclen and an MRI contrast agent comprising same. The novel compound and MRI contrast agent of the present invention are characterized by having a structure represented by ...  
WO/2024/048409A1
Provided is a composite obtained by bonding, with high strength, a support having a metal part and a metal-organic framework (MOF). The composite comprises a support having a metal part and a metal-organic framework formed on the surfa...  
WO/2023/008865A9
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure represented by formula I wherein Ar1 is selected from the group c...  
WO/2024/047571A1
The present invention provides new co-crystal derivatives (coformers: Caffeine, Picolinic Acid, Quinaldic Acid, and Pyridoxine) of 4-((1-hydroxy-1,3- dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile (Crisaborole) having varied dissolut...  
WO/2023/240266A9
A composition comprising lithium Li+ and boron cluster weakly-coordinating anions and methods of preparing the same are disclosed. The weakly-coordinating boron cluster anion comprises a formula of [BnXx(OR)y]2- or a salt thereof, wherei...  
WO/2024/042952A1
The present invention provides: an acid generator which exhibits excellent solubility in a cationically curable compound; and a curable composition which is rapidly cured when subjected to a heat treatment, and which forms a cured produc...  
WO/2024/044536A2
The attachment of glucose to drugs and imaging agents enables cancer cell targeting via interactions with GLUT1 overexpressed on the cell surface. The present technology describes a biomimetic approach for the design of a multivalent glu...  
WO/2024/042951A1
Provided is an acid generator that has superior solubility in cation-curable compounds. This acid generator includes: a salt (1) of a cation represented by formula (c-1) and a monovalent counter anion; and a salt (2) of a cation repres...  
WO/2024/037635A1
The present invention pertains to the biomedical field, and particularly relates to a trifunctional compound comprising a fibroblast activation protein (FAP) targeting moiety. The present invention also relates to a pharmaceutical compos...  
WO/2024/040009A2
This invention pertains to the discovery and development of novel inhibitors for Methionine Aminopeptidase 2 (MetAP2). The MetAP2 inhibitors have demonstrated efficacy in therapeutic applications for treating various conditions, includin...  
WO/2024/038356A1
The present disclosure includes synthetic methods for preparing certain substituted 1-aryl-1'-heteroaryl and 1,1'-biheteroaryl compounds, which can be used to treat, ameliorate, and/or prevent hepatitis B virus (HBV) infections in a pati...  
WO/2024/038842A1
The present invention relates to a compound represented by formula (I) (in the formula, R1 is a C1-4 alkyl group or the like, and A1 and A2 are each independently a group, etc. represented by formula (II), in which R2 and R3 are each ind...  
WO/2024/036097A1
Provided herein are heteroaromatic macrocyclic ether compounds and isotopologues thereof, or a stereoisomer, or a mixture of stereoisomers thereof, or a pharmaceutically acceptable salt thereof, and methods of treating, preventing or man...  
WO/2024/031919A1
The present invention belongs to the field of organic synthesis, and particularly relates to a carbazole fused boron-nitrogen derivative, a preparation method therefor, and the use thereof. The present invention provides the preparation ...  
WO/2024/035871A1
Disclosed are compounds, compositions, and methods useful for boron neutron capture therapy.  
WO/2024/023332A1
The invention relates to novel silicon-based fluoride acceptor groups (SiFA groups) of the following formulae (Ia, Ib, Ic) as well as to compounds suitable for use in radiopharmacy comprising such groups, wherein R1 and R2 are each a lin...  
WO/2024/024818A1
[Problem] To provide a simpler method for producing a high-quality metal-organic structure. [Solution] The method for producing a metal-organic structure according to the present invention comprises: providing a stirrer equipped with a...  
WO/2024/019972A1
The described process synthesizes a halide-free single-site borane compound product tris(ortho-carboranyl)borane, or BoCb3. BoCb3 has Lewis superacid properties. The compounds, BoCb3, are thermally stable, and not reactive towards oxygen...  
WO/2023/250157A9
Disclosed are compounds for inhibiting lipoamide dehydrogenase (Lpd), and methods of treating tuberculosis.  
WO/2024/016976A1
The present invention relates to a FAP-α specific tumor diagnostic imaging agent, in particular, the present invention relates to a compound of formula (I), a FAP-α specific tumor imaging agent formed by coordination of the compound of...  
WO/2024/016963A1
Provided are an organic electroluminescent material containing a B-N structure and a use thereof, the general structural formula thereof being as shown in formulas (A) and (B). Based on a conventional B-N resonance structure, in this typ...  
WO/2024/012365A1
Provided is an organic compound, which can be used in an organic electroluminescent device. The compound has the characteristics of high luminous efficiency, narrow spectral emission and high stability; and an organic electroluminescent ...  
WO/2024/015861A1
Provided herein are methods of preparation of compound 101. Also provided are intermediate compounds useful in the preparation of compound 101, and methods of preparation of those intermediate compounds.  
WO/2024/013709A1
The present invention relates to specific compounds, a material, preferably an emitter material, for an organic electroluminescence device comprising said specific compounds, an organic electroluminescence device comprising said specific...  
WO/2024/008033A1
Provided are a class of 7-((five-membered heterocyclic)methyl)-8-carboxylic acid-benzo cyclic borate derivatives represented by formula (I) and uses thereof. The derivative has good broad-spectrum inhibitory activity on clinically common...  
WO/2024/003087A1
The present application relates to dyes containing fused tetracyclic bis-boron containing heterocycle and their uses as fluorescent labels. These dyes may be used as fluorescent labels for nucleotides in nucleic acid sequencing applicati...  
WO/2024/002889A1
The invention relates to compounds of formula (I) : as well as stereoisomeric forms, mixtures of stereoisomeric forms, and salts thereof, wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Compounds of formula (I) are particularly ...  
WO/2024/006337A1
The present disclosure relates to cyclic boronic esters and salts thereof for use as immunoproteasome inhibitors. The disclosure further relates to pharmaceutical compositions, methods of preparing, crystal and polymorph forms, and metho...  
WO/2024/006776A1
The application relates to bifunctional compounds which act as degraders of the estrogen receptor alpha (ERα) and are useful for treating disorders associated with ERα-mediated transcription regulation such as endometriosis and cancer....  
WO/2024/005118A1
The purpose of the present invention is to provide an organic electroluminescent element which achieves excellent drive voltage characteristics and excellent current efficiency characteristics at the same time, while having a small chang...  
WO/2024/006781A1
The application relates to bifunctional compounds of the general formula I-3' which act as degraders of the estrogen receptor alpha(ERα) and are useful for treating disorders associated with ERα-mediated transcription regulation such a...  

Matches 1 - 50 out of 8,350